Patrick McGrady

3.9k citations

19 papers · 1.5k indexed · h-index 16

Impact in

Neurology top 1%
- Neuroblastoma Research and Treatments
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Neurology 18
- Neuroblastoma Research and Treatments 18
- Neurofibromatosis and Schwannoma Cases 2
Cancer Research 6
- Cancer, Hypoxia, and Metabolism 6

Co-authors: Wendy B. London (15 shared papers)Susan L. Cohn (9 shared papers)John M. Maris (7 shared papers)Yaël P. Mossé (3 shared papers)Katherine K. Matthay (3 shared papers)A. Thomas Look (3 shared papers)Hiroyuki Shimada (3 shared papers)Garrett M. Brodeur (2 shared papers)
Journals: Clinical Cancer Research (5 papers)Journal of Clinical Oncology (4 papers)Cancer Cell (1 paper)Journal of Nuclear Medicine (1 paper)Bone Marrow Transplantation (1 paper)
Partner nations: United States Switzerland Belgium

In The Last Decade

Patrick McGrady

19 papers receiving 1.5k citations

Peers

Countries citing papers authored by Patrick McGrady

Since Specialization

Citations

This map shows the geographic impact of Patrick McGrady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick McGrady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick McGrady more than expected).

Fields of papers citing papers by Patrick McGrady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick McGrady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick McGrady. The network helps show where Patrick McGrady may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick McGrady, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick McGrady Line = papers co-authored together Patrick McGrady links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma New England Journal of Medicine ·Edward F. Attiyeh, Wendy B. London, Yaël P. Mossé, Qun Wang, Cynthia Winter, Deepa Khazi, Patrick McGrady, Robert C. Seeger, A. Thomas Look, Hiroyuki Shimada, Garrett M. Brodeur, Susan L. Cohn, Katherine K. Matthay, John M. Maris	2005	395
2	ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma Cancer Cell ·Scott C. Bresler, Daniel A. Weiser, Peter J. Huwe, Jin H. Park, Kateryna Krytska, Hannah T. Ryles, Marci Laudenslager, Eric Rappaport, Andrew Wood, Patrick McGrady, Michael D. Hogarty, Wendy B. London, Ravi Radhakrishnan, Mark A. Lemmon, Yaël P. Mossé	2014	252
3	Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group Journal of Nuclear Medicine ·Gregory A. Yanik, Marguerite T. Parisi, Barry L. Shulkin, Arlene Naranjo, Susan G. Kreissman, Wendy B. London, Judith G. Villablanca, John M. Maris, Julie R. Park, Susan L. Cohn, Patrick McGrady, Katherine K. Matthay	2013	133
4	A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants Annals of Surgery ·Jed G. Nuchtern, Wendy B. London, Carol E. Barnewolt, Arlene Naranjo, Patrick McGrady, James D. Geiger, Lisa Diller, Mary Lou Schmidt, John M. Maris, Susan L. Cohn, Robert C. Shamberger	2012	113
5	Racial and Ethnic Disparities in Risk and Survival in Children With Neuroblastoma: A Children's Oncology Group Study Journal of Clinical Oncology ·Tara O. Henderson, Ravi Bhatia, Navin Pinto, Wendy B. London, Patrick McGrady, Catherine Crotty, Can‐Lan Sun, Susan L. Cohn	2010	106
6	Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival PLoS ONE ·Isabella Bray, Kenneth Bryan, Suzanne Prenter, Patrick G. Buckley, Niamh H. Foley, Derek M. Murphy, Leah Alcock, Pieter Mestdagh, Jo Vandesompele, Frank Speleman, Wendy B. London, Patrick McGrady, Desmond G. Higgins, Anne O’Meara, Maureen J. O’Sullivan, Raymond L. Stallings	2009	96
7	Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group Clinical Cancer Research ·Judith G. Villablanca, Wendy B. London, Arlene Naranjo, Patrick McGrady, Matthew M. Ames, Joel M. Reid, Renee M. McGovern, Sarah A. Buhrow, Hollie Jackson, Enno Stranzinger, Brenda J. Kitchen, Paul M. Sondel, Marguerite T. Parisi, Barry L. Shulkin, Gregory A. Yanik, Susan L. Cohn, C. Patrick Reynolds	2011	80
8	Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group Cancer ·Larry Wang, Rie Suganuma, Naohiko Ikegaki, Xao X. Tang, Arlene Naranjo, Patrick McGrady, Wendy B. London, Michael D. Hogarty, Julie M. Gastier‐Foster, A. Thomas Look, Julie R. Park, John M. Maris, Susan L. Cohn, Robert C. Seeger, Hiroyuki Shimada	2013	58
9	Focal Adhesion Kinase Expression in Human Neuroblastoma: Immunohistochemical and Real-time PCR Analyses Clinical Cancer Research ·Elizabeth A. Beierle, Nicole Massoll, Joseph E. Hartwich, Elena Kurenova, Vita Golubovskaya, William G. Cance, Patrick McGrady, Wendy B. London	2008	51
10	Mechanisms of CHD5 Inactivation in Neuroblastomas Clinical Cancer Research ·Hiroshi Koyama, Tiangang Zhuang, Jennifer E. Light, Venkatadri Kolla, Mayumi Higashi, Patrick McGrady, Wendy B. London, Garrett M. Brodeur	2012	48
11	Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma:rs1800795(Promoter) andrs8192284(Receptor) Clinical Cancer Research ·Joanne Lagmay, Wendy B. London, Thomas G. Gross, Amanda Termuhlen, Nicholas J. Sullivan, Amy Axel, Bethany L. Mundy-Bosse, Mark Ranalli, Jason Canner, Patrick McGrady, Brett M. Hall	2009	36
12	A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children’s Oncology Group study ANBL00P1 Bone Marrow Transplantation ·Alix E. Seif, Arlene Naranjo, David L. Baker, Nancy Bunin, Morris Kletzel, C. Kretschmar, John M. Maris, Patrick McGrady, Daniel von Allmen, Susan L. Cohn, Wendy B. London, J R Park, Lisa Diller, Stephan A. Grupp	2013	35
13	Influence of neuroblastoma stage on serum‐based detection of MYCN amplification Pediatric Blood & Cancer ·Valérie Combaret, Michael D. Hogarty, Wendy B. London, Patrick McGrady, Isabelle Iacono, Stéphanie Bréjon, Katrien Swerts, Rosa Noguera, Nicole Groß, Raphaël F. Rousseau, Alain Puisieux	2009	29
14	Survivin mRNA Levels Are Associated With Biology of Disease and Patient Survival in Neuroblastoma: A Report From the Children's Oncology Group Journal of Pediatric Hematology/Oncology ·Michal A. Miller, Kensuke Ohashi, Xiaoyan Zhu, Patrick McGrady, Wendy B. London, Michael D. Hogarty, Anthony D. Sandler	2006	25
15	Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study Clinical Cancer Research ·Lisa A. Moreau, Patrick McGrady, Wendy B. London, Hiroyuki Shimada, Susan L. Cohn, John M. Maris, Lisa Diller, A. Thomas Look, Rani E. George	2006	23
16	The Availability of a k-out-of-n:G Network IEEE Transactions on Reliability ·Patrick McGrady	1985	17
17	Chromosome arm 11q deletion predicts for neuroblastoma outcome: A Children’s Oncology Group study Journal of Clinical Oncology ·Edward F. Attiyeh, Yaël P. Mossé, Qiangfeng Wang, Cynthia Winter, Deepa Khazi, George Hii, Patrick McGrady, Katherine K. Matthay, W. B. London, John M. Maris	2005	14
18	Racial and ethnic disparities in disease presentation and survival among children with neuroblastoma (NBL): A Children's Oncology Group (COG) study. Journal of Clinical Oncology ·Susan L. Cohn, Shruti Bhatia, W. B. London, Patrick McGrady, Catherine Crotty, Chuanyu Sun, T. O. Henderson	2010	4
19	MIBG scoring as a prognostic indicator in patients with stage IV neuroblastoma: A COG study. Journal of Clinical Oncology ·Greg Yanik, Marguerite T. Parisi, Arlene Naranjo, K. K. Matthay, W. B. London, Patrick McGrady, Susan G. Kreissman, Barry L. Shulkin	2010	4

About Patrick McGrady

Patrick McGrady is a scholar working on Neurology, Cancer Research, Oncology, Immunology and Allergy and Epidemiology, having authored 19 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (18 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer therapeutics and mechanisms (5 papers), Adrenal and Paraganglionic Tumors (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Lung Cancer Research Studies (4 papers), Neurofibromatosis and Schwannoma Cases (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Neurology (1.1k citations), Cancer Research (610 citations), Oncology (337 citations), Molecular Biology (785 citations) and Genetics (92 citations). Patrick McGrady has collaborated with scholars based in United States, Switzerland and Belgium. Frequent co-authors include Wendy B. London, Susan L. Cohn, John M. Maris, Yaël P. Mossé, Katherine K. Matthay, A. Thomas Look, Hiroyuki Shimada, Garrett M. Brodeur, Arlene Naranjo and Robert C. Seeger. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Cancer Cell, Journal of Nuclear Medicine and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact